Development and internal validation of a steatosis index in primary biliary cholangitis: a retrospective single-center study
Hepatic steatosis may coexist with primary biliary cholangitis (PBC), but PBC-related biochemical and lipid abnormalities may complicate its identification using laboratory-based indices. We aimed to develop and internally validate a PBC-specific steatosis index (PSI) using routinely collected variables. This retrospective single-center study included adults with biopsy-confirmed PBC during 2016–2025; hepatic steatosis was defined histologically as involvement of at least 5% of hepatocytes. Missing predictors were multiply imputed within training partitions. A genetic-algorithm formula-search procedure was evaluated by repeated nested five-fold cross-validation against least absolute shrinkage and selection operator (LASSO), a prespecified clinical model, and six conventional indices. Among 681 participants, 98 (14.4%) had histological steatosis. The locked two-variable PSI formula was 5 × triglycerides − 2 × diabetes status (1 = recorded diabetes; 0 = no recorded diabetes). The PSI procedure achieved an out-of-fold AUC of 0.703 (95% CI, 0.646–0.757), Brier score of 0.116, and calibration slope of 1.276. At the exploratory OOF probability cutoff of 0.131, sensitivity was 72.4%, specificity 59.3%, positive predictive value 23.1%, and negative predictive value 92.8%. PSI outperformed HSI and TyG-BMI after multiplicity adjustment but did not demonstrate superiority over TyG or LASSO. In this biopsy-confirmed PBC cohort, the PSI procedure showed moderate internally assessed discrimination for steatosis. The transparent and readily reproducible two-variable formula may help prioritize patients for further steatosis assessment when imaging-based evaluation is not readily available, but requires independent external validation before clinical implementation.
Authors
- Hong-Li Liu (ORCID: https://orcid.org/0000-0001-6633-6795)
- Yongfeng Yang (ORCID: https://orcid.org/0000-0002-3214-0038)
- S S Li (ORCID: https://orcid.org/0000-0003-3983-2915)
- An-Ling Zhou
- Ling Li (ORCID: https://orcid.org/0009-0008-2040-8456)
- Qun-Zeng Danzeng
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing Second Hospital (CN)
- Southeast University (CN)
- Nanjing Medical University (CN)
- Nanjing University (CN)
Publication Details
- Journal
- BMC Gastroenterology
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1186/s12876-026-05585-9
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 0.00